Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

被引:5
|
作者
Redondo, Alfredo [1 ,2 ]
Paradela-Dobarro, Beatriz [3 ,4 ]
Moscoso, Isabel [3 ,4 ]
Moure-Alvarez, Maria [1 ,2 ]
Cebro-Marquez, Maria [3 ]
Gonzalez-Juanatey, Jose Ramon [1 ,2 ,3 ,4 ]
Garcia-Seara, Javier [1 ,2 ,3 ,4 ]
Alvarez, Ezequiel [4 ,5 ]
机构
[1] Complexo Hosp Univ Santiago de Compostela CHUS, Serv Cardiol, SERGAS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[2] Complexo Hosp Univ Santiago de Compostela CHUS, Unidad Hemodinam, SERGAS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[3] Complexo Hosp Univ Santiago de Compostela CHUS, Unidad Hemodinam, Inst Invest Sanitaria Santiago de Compostela IDIS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[4] CIBERCV, Madrid, Spain
[5] Complexo Hosp Univ Santiago de Compostela CHUS, Lab 6, Inst Invest Sanitaria Santiago de Compostela IDIS, SERGAS, Edif Consultas Externas,Planta 2, Santiago De Compostela 15706, A Coruna, Spain
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2021年 / 99卷 / 07期
关键词
Acute myocardial infarction with ST-segment elevation; Post-infarction remodeling; Galectin-3; Soluble RAGE; Biomarkers; GLYCATION END-PRODUCTS; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; SERUM GALECTIN-3; HEART-FAILURE; RECEPTOR; FIBROSIS; EXPRESSION; S100B; ASSOCIATION;
D O I
10.1007/s00109-021-02054-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Post-infarction remodeling is a clinical problem with no curative treatment. Our objective was to search for new biomarkers of cardiac remodeling that have clinical value after ST-segment elevation myocardial infarction (STEMI). This pilot study enrolled 67 consecutive patients with de novo STEMI who underwent revascularization by primary angioplasty. Echocardiography studies of cardiac function were completed during the first 48 h post-STEMI and after 6 months of follow-up. Galectin-3 and soluble receptor for advanced glycation end products (sRAGE) were tested in the peripheral venous blood during the 24 h post-infarction. Cardiac remodeling was defined as changes >= 15% in the left ventricular end-systolic volume (LVESV) or > 10% in the left atrial area (LAA). An inverse association was found between galectin-3 (r(s) = - 0.296; p < 0.001) and sRAGE (r(s) = - 0.327; p < 0.001) levels and the basal left ventricle ejection fraction (LVEF). However, only galectin-3 was directly associated with the increase in LVESV (r(s) = 0.389; p = 0.007) and LVEDV (r(s) = 0.314; p = 0.031) during the follow-up. sRAGE was inversely related to the change in LAA (r(s) = - 0.320; p = 0.032). These data are consistent with galectin-3, but not sRAGE levels, as a predictor of left ventricle remodeling (OR 1.036, 95% CI 1.002-1.071; p = 0.039). Galectin-3 and sRAGE levels that were measured during hospitalization are inversely related to basal LVEF after a STEMI. Galectin-3 levels are a predictor of adverse post-STEMI LV remodeling, whereas sRAGE levels exhibited an inverse relationship with left atrial remodeling. Key messages Post-infarction remodeling is a clinical problem with no curative treatment. New biomarkers for remodeling after acute myocardial infarction were explored. Early post-STEMI galectin-3 and soluble RAGE are inversely related with left ventricle function. Galectin-3 levels were predictors of adverse post-STEMI left ventricle remodeling. Soluble RAGE levels were associated with left atrial remodeling.
引用
收藏
页码:943 / 953
页数:11
相关论文
共 50 条
  • [1] Galectin-3 and post-myocardial infarction cardiac remodeling
    Meijers, Wouter C.
    van der Velde, A. Rogier
    Pascual-Figal, Domingo A.
    de Boer, Rudolf A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 115 - 121
  • [2] Galectin-3 expression in cardiac remodeling after myocardial infarction
    Sanchez-Mas, J.
    Lax, A.
    Asensio-Lopez, M. C.
    Fernandez-Del Palacio, M. J.
    Caballero, L.
    Garrido, I. P.
    Pastor, F.
    Januzzi, J. L.
    Pascual-Figal, D. A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : E98 - E101
  • [3] Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades
    Wang, Xiaoyin
    Gaur, Meenakshi
    Mounzih, Khalid
    Rodriguez, Hilda J.
    Qiu, Huiliang
    Chen, Ming
    Yan, Liqiu
    Cooper, Brian A.
    Narayan, Shilpa
    Derakhshandeh, Ronak
    Rao, Poonam
    Han, Daniel D.
    Nabavizadeh, Pooneh
    Springer, Matthew L.
    John, Constance M.
    CARDIOVASCULAR RESEARCH, 2023, 119 (15) : 2536 - 2549
  • [4] Galectin-3 in cardiac remodeling and heart failure
    De Boer R.A.
    Yu L.
    Van Veldhuisen D.J.
    Current Heart Failure Reports, 2010, 7 (1) : 1 - 8
  • [5] Labeling galectin-3 for the assessment of myocardial infarction in rats
    Arias, Teresa
    Petrov, Artiom
    Chen, Jiqiu
    de Haas, Hans
    Perez-Medina, Carlos
    Strijkers, Gustav J.
    Hajjar, Roger J.
    Fayad, Zahi A.
    Fuster, Valentin
    Narula, Jagat
    EJNMMI RESEARCH, 2014, 4
  • [6] Macrophage activation and polarization in post-infarction cardiac remodeling
    Gombozhapova, Aleksandra
    Rogovskaya, Yuliya
    Shurupov, Vladimir
    Rebenkova, Mariya
    Kzhyshkowska, Julia
    Popov, Sergey V.
    Karpov, Rostislav S.
    Ryabov, Vyacheslav
    JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24 : 1 - 11
  • [7] Macrophage activation and polarization in post-infarction cardiac remodeling
    Aleksandra Gombozhapova
    Yuliya Rogovskaya
    Vladimir Shurupov
    Mariya Rebenkova
    Julia Kzhyshkowska
    Sergey V. Popov
    Rostislav S. Karpov
    Vyacheslav Ryabov
    Journal of Biomedical Science, 24
  • [8] Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
    Yu, Lili
    Ruifrok, Willem P. T.
    Meissner, Maxi
    Bos, Eelke M.
    van Goor, Harry
    Sanjabi, Bahram
    van der Harst, Pim
    Pitt, Bertram
    Goldstein, Irwin J.
    Koerts, Jasper A.
    van Veldhuisen, Dirk J.
    Bank, Ruud A.
    van Gilst, Wiek H.
    Sillje, Herman H. W.
    de Boer, Rudolf A.
    CIRCULATION-HEART FAILURE, 2013, 6 (01) : 107 - +
  • [9] Value of Galectin-3 in Acute Myocardial Infarction
    Li, Mingxing
    Yuan, Yong
    Guo, Kai
    Lao, Yi
    Huang, Xuansheng
    Feng, Li
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (04) : 333 - 342
  • [10] Post-infarction cardiac remodeling-differential biomarkers for left atrial and left ventricular remodeling
    Selejan, Simina-Ramona
    Hohl, Mathias
    Boehm, Michael
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (07): : 957 - 958